SEC 13F Intelligence

Artia Global Partners LP / APLSUSD

Artia Global Partners LP’s Apellis Pharmaceuticals Inc Position

Does Artia Global Partners LP own Apellis Pharmaceuticals Inc (APLSUSD)? Not currently — the last reported position was 102.9K shares worth $9M in Q2 2023; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$9M
Q2 2023
Shares
102.9K
% of Portfolio
+3.23%
Quarters Held
1
position exited

Position History APLSUSD

Reported value by quarter
Q2 ’23: $9MQ2 ’23filingsflow.com
QuarterSharesValue% of Portfolio
Q2 2023102.9K$9M+3.23%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Artia Global Partners LP’s full portfolio or all institutional holders of APLSUSD.